Uro-oncologic aspects of Covid-19 research
Fazekas Tamás dr., Csizmarik Anita, Szarvas Tibor dr., Szűcs Miklós dr., Nyirády Péter dr.
Semmelweis Egyetem, Urológiai Klinika, Budapest (igazgató: Nyirády Péter dr.)
The SARS-2 Coronavirus and its related disease Covid-19 has dramatically changed our medical practice and daily lives in the last few months. During the fight against the epidemic, valuable scientific data have been obtained from the field of uro-oncology. Both the TMPRSS2 protein which enables viral cell entry, and Bacillus Calmette-Guérin (BCG) vaccination, which seems to have protective effect against the virus have important urologic aspects.
In this review we summarize the latest results on these topics and highlight unique opportunities for further research.